Detalles de la búsqueda
1.
Allogeneic Stem Cell Transplantation Provides Durable Remission in Patients with Primary Mediastinal Large B Cell Lymphoma.
Biol Blood Marrow Transplant
; 25(12): 2383-2387, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31394277
2.
Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report.
Biol Blood Marrow Transplant
; 24(6): 1187-1195, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29410180
3.
Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma.
Biol Blood Marrow Transplant
; 24(3): 514-520, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29196080
4.
Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BCNU, Etoposide, Cytarabine, and Melphalan for Non-Hodgkin Lymphoma: The Role of Histology.
Biol Blood Marrow Transplant
; 23(6): 922-929, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28267593
5.
Long-Term Results of High-Dose Therapy and Autologous Stem Cell Transplantation for Mantle Cell Lymphoma: Effectiveness of Maintenance Rituximab.
Biol Blood Marrow Transplant
; 23(11): 1861-1869, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28733266
6.
Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network lymphoma outcomes project.
Cancer
; 121(7): 1032-9, 2015 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25492236
7.
Comparison of referring and final pathology for patients with T-cell lymphoma in the National Comprehensive Cancer Network.
Cancer
; 120(13): 1993-9, 2014 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24706502
8.
R-CHOP with iodine-131 tositumomab consolidation for advanced stage diffuse large B-cell lymphoma (DLBCL): SWOG S0433.
Br J Haematol
; 166(3): 382-9, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24749780
9.
Comparative outcome of initial therapy for younger patients with mantle cell lymphoma: an analysis from the NCCN NHL Database.
Blood
; 119(9): 2093-9, 2012 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22234679
10.
Plerixafor plus granulocyte colony-stimulating factor improves the mobilization of hematopoietic stem cells in patients with non-Hodgkin lymphoma and low circulating peripheral blood CD34+ cells.
Biol Blood Marrow Transplant
; 19(4): 670-5, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23333777
11.
Stem cell transplantation for follicular lymphoma relapsed/refractory after prior rituximab: a comprehensive analysis from the NCCN lymphoma outcomes project.
Cancer
; 119(20): 3662-71, 2013 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-23921646
12.
Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database.
Br J Haematol
; 163(4): 487-95, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24111533
13.
Safety and efficacy of upfront plerixafor + G-CSF versus placebo + G-CSF for mobilization of CD34(+) hematopoietic progenitor cells in patients ≥60 and <60 years of age with non-Hodgkin's lymphoma or multiple myeloma.
Am J Hematol
; 88(12): 1017-23, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23907769
14.
Plerixafor plus granulocyte colony-stimulating factor versus placebo plus granulocyte colony-stimulating factor for mobilization of CD34(+) hematopoietic stem cells in patients with multiple myeloma and low peripheral blood CD34(+) cell count: results of a subset analysis of a randomized trial.
Biol Blood Marrow Transplant
; 18(10): 1564-72, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22683613
15.
Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma.
Biol Blood Marrow Transplant
; 17(8): 1146-53, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21126595
16.
Double-hit Signature with TP53 Abnormalities Predicts Poor Survival in Patients with Germinal Center Type Diffuse Large B-cell Lymphoma Treated with R-CHOP.
Clin Cancer Res
; 27(6): 1671-1680, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33414134
17.
Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation.
J Hematol Oncol
; 11(1): 87, 2018 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29954415
18.
Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation.
J Clin Oncol
; 35(1): 24-31, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28034071
19.
Interleukin-2 after autologous stem-cell transplantation for adult patients with acute myeloid leukemia in first complete remission.
J Clin Oncol
; 21(4): 615-23, 2003 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12586797
20.
Total body irradiation, etoposide, cyclophosphamide, and autologous peripheral blood stem-cell transplantation followed by randomization to therapy with interleukin-2 versus observation for patients with non-Hodgkin lymphoma: results of a phase 3 randomized trial by the Southwest Oncology Group (SWOG 9438).
Blood
; 111(8): 4048-54, 2008 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18256325